Biotech leaders: Macroeconomics, US policy shifts making M&A harder
### Navigating Policy Whiplash: Can AI De-Risk M&A in an Unpredictable World? A recent survey of CEOs and investors sent...
### Navigating Policy Whiplash: Can AI De-Risk M&A in an Unpredictable World? A recent survey of CEOs and investors sent...
### Beyond the Hype: Why Europe's AI Med-Tech Startups are Facing a Capital Crisis Artificial intelligence promises to revolutionize medicine....
### Beyond Brute Force: Why Mixture-of-Experts is Reshaping the LLM Landscape For the last several years, the prevailing mantra in...
# Smarter, Not Just Bigger: The Rise of Mixture-of-Experts in AI For the past several years, a simple mantra has...
# The AI Cambrian Explosion or a Transformer Monoculture? The last few years in artificial intelligence have felt like a...
# The Great Distillation: Why the Future of AI is Small and Specialized For the past few years, the AI...
# Unlocking Efficiency: How Mixture-of-Experts (MoE) is Reshaping LLM Architecture For the past few years, the dominant narrative in large...
# The LLM Is Not Your Application: A Systems Approach to Generative AI We are living through a Cambrian explosion...
# Goliath vs. David: Why the Future of AI is Specialized For the past several years, the narrative in artificial...
### Beyond the Context Window: The Dawn of Dynamic State Models For the past several years, the story of Large...